OptiNose, Inc.


1.06 (USD) • At close July 19, 2024
Bedrijfsnaam OptiNose, Inc.
Symbool OPTN
Munteenheid USD
Prijs 1.06
Beurswaarde 153,529,340
Dividendpercentage 0%
52-weken bereik 0.8 - 2.1
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Ramy A. Mahmoud M.D., M.P.H.
Website https://www.optinose.com

An error occurred while fetching data.

Over OptiNose, Inc.

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment

Vergelijkbare Aandelen

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.


5.33 USD

Longeveron Inc. logo

Longeveron Inc.


3.29 USD

Biomea Fusion, Inc. logo

Biomea Fusion, Inc.


5.04 USD

Omeros Corporation logo

Omeros Corporation


4.88 USD

Chimerix, Inc. logo

Chimerix, Inc.


0.9 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.


3.08 USD

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.


1.27 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)